Inversago
acquired by Novo Nordisk10 known investors
Find your way into Inversago
Sign up to see every warm intro you have to Inversago
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inversago team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Investors · 10
How we know: adMare BioInnovations's portfolio page · funding news · press coverage · Not right? Tell us
How we know: a partner's Signal profile · funding news · theglobeandmail.com · Not right? Tell us
How we know: Genesys Capital's portfolio page · funding news · theglobeandmail.com · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: a partner's Signal profile · theglobeandmail.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Tarnagulla Ventures's portfolio page · Not right? Tell us
How we know: theglobeandmail.com · Not right? Tell us
How we know: a partner's Signal profile · funding news · theglobeandmail.com · Not right? Tell us
Also in the syndicate · 1
Founder mafia
3 people who came through Inversago went on to found or lead other companies.
Frequently asked questions
- What does Inversago do?
- Portfolio company acquired by Novo Nordisk for $1.1B USD.
- Who are Inversago's investors?
- Inversago's investors include adMare BioInnovations, AmorChem, Genesys Capital, JDRF T1D Fund, New Enterprise Associates (NEA), Tarnagulla Ventures, Amgen Ventures, Fonds de solidarité FTQ and 1 more.
- Who acquired Inversago?
- Inversago was acquired by Novo Nordisk.




